Data from one of the largest clinical trials ever conducted in ALS to be part of PRO-ACT database.
Prize4Life and Knopp Neurosciences Announce Donation of Empower Phase 3 Data to PRO-ACT Database
Knopp Biosciences, Inc. has agreed to donate placebo data from the phase III dexpramipexole trial to the award-winning PRO-ACT Platform, created by the NCRI and Prize4Life in partnership with NEALS. The dataset will be expanded to include treatment-arm data when research into dexpramipexole for ALS is complete. NCRI and NEALS in collaboration with Prize4life will continue to foster encouraging collaborative partnerships between academia and industry via this valuable resource.